Fever Clinical Trial
Official title:
Universal Versus Conditional Follow Up for Children With Unclassified Fever at the Community Level: A Cluster-Randomized, Community-based, Non-Inferiority Trial in Kalemie, Democratic Republic of Congo (DRC)
Providers in integrated Community Case Management (iCCM) programs in low resource settings often see children without any danger signs, presenting with fever but not having pneumonia, malaria, or diarrhea. These children are sent home (often with analgesic only), and caretakers are advised to return in 2 or 3 days. In this study, we are evaluating if conditional return advice (i.e. return in 2 or 3 day only if your child is still sick") results in the same proportion of children remaining with fever one week after identification, as the current universal return advice.
Fevers in childhood are common and usually self resolve. In rural Democratic Republic of
Congo (and many other settings), when a febrile child presents to a community health worker
(CHW), the child is assessed for malaria, pneumonia, and diarrhea, and other danger signs,
according to World Health Organization (WHO) guidelines for integrated Community Case
Management (iCCM) of childhood illnesses. In the cases where 1) there are no danger signs
present, and 2) malaria, pneumonia, and diarrhea have been ruled out, the CHW provides an
antipyretic only, sends the child home, and advises all such cases to come back in 3 days.
We hypothesize, however, that health outcomes for these cases will be equivalent if the CHW
advises to come back in 3 days, only if symptoms have not resolved.
To test this hypothesis, we are conducting a cluster-randomized, community-based
non-inferiority trial in two zones of Kalemie, Katanga Province, Democratic Republic of
Congo. In this area, the International Rescue Committee (IRC) has been supporting the
training, scale-up, and rollout of community health workers who conduct iCCM as per WHO
guidelines and with Ministry of Health oversight. CHWs have unique non-overlapping catchment
areas, and groups of CHWs (average 5-7) are associated with health clinics. We will utilize
this group structure as the unit of randomization; health clinics (and thereby, groups of
CHWs) will be randomly allocated to one of two groups in terms of the advice given to
caretakers of children who have no danger signs, have neither malaria, pneumonia, nor
diarrhea, and are thus classified as having fever of non-identified origin.
- Group 1 (Universal follow-up): CHWs in this group will advise caretakers to follow up
in 3 days
- Group 2 (Conditional follow-up): CHWs in this group will advise caretakers to follow up
in 3 days if symptoms/signs remain the same (or worsen).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03706599 -
Fever Infants and Therapeutic Education in Emergency Department
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Not yet recruiting |
NCT01782183 -
Thermographic Characteristics of Sore Throat by Thermographic Camera
|
N/A | |
Withdrawn |
NCT00800696 -
Preventive Oral Care
|
N/A | |
Completed |
NCT02689193 -
IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres
|
||
Completed |
NCT02212990 -
The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine
|
N/A | |
Completed |
NCT01869699 -
Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults
|
Phase 4 | |
Completed |
NCT01911143 -
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
|
N/A | |
Completed |
NCT01194557 -
Introducing Rapid Diagnostic Tests Into the Private Health Sector
|
N/A | |
Completed |
NCT01559675 -
Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
|
N/A | |
Completed |
NCT00940654 -
The Fever and Antipyretic in Critically Illness Evaluation Study
|
N/A | |
Completed |
NCT00969176 -
Pharmacokinetics, -Dynamics and Safety of Intravenous Paracetamol in Neonates
|
Phase 2/Phase 3 | |
Recruiting |
NCT00729976 -
Oral Versus Rectal Ibuprofen for Fever in Young Children - a Randomized Control Study.
|
Phase 4 | |
Recruiting |
NCT00389272 -
Adding a Second Drug for Febrile Children Treated With Acetaminophen
|
N/A | |
Completed |
NCT00257790 -
The Tobramycin Study
|
Phase 4 | |
Recruiting |
NCT05033613 -
Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
|
||
Recruiting |
NCT06061575 -
Comparison of the Efficacy of Paracetamol and Ibuprofen in the Management of Fever in Sepsis Patients
|
Phase 4 | |
Recruiting |
NCT06038617 -
Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
|
Phase 4 | |
Completed |
NCT01946594 -
Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV
|
Phase 4 |